Author details

Full Name

Eytan Ruppin

Affiliation

National Cancer Institute

ORCID

Career Start Year

1971

Papers

316

H Index

Expertise

CM4AI Collaborator

Trey Ideker (CM4AI)

PMID	Paper Title	Journal Title	Published Year
38048593	Transcriptional control of leukemogenesis by the chromatin reader SGF29.	Blood	2024
36631162	Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma.	J Immunother Cancer	2023
37859800	Elevated A-to-I RNA editing in COVID-19 infected individuals.	NAR Genom Bioinform	2023
38076973	Charting the transcriptomic landscape of primary and metastatic cancers in relation to their origin and target normal tissues.	bioRxiv	2023
37486616	A comprehensive analysis of adverse events in the first 30Â days of phase 1 pediatric CAR T-cell trials.	Blood Adv	2023
37852738	Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer.	J Immunother Cancer	2023
37845222	Expanding PROTACtable genome universe of E3 ligases.	Nat Commun	2023
37790315	Prediction of cancer treatment response from histopathology images through imputed transcriptomics.	Res Sq	2023
37886558	Deactivation of ligand-receptor interactions enhancing lymphocyte infiltration drives melanoma resistance to Immune Checkpoint Blockade.	bioRxiv	2023
37835579	Pan-Cancer Analysis of Patient Tumor Single-Cell Transcriptomes Identifies Promising Selective and Safe Chimeric Antigen Receptor Targets in Head and Neck Cancer.	Cancers (Basel)	2023
37726418	Biomarkers for immunotherapy of hepatocellular carcinoma.	Nat Rev Clin Oncol	2023
37090544	Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency and Long-Term Risk of Immune-Related diseases.	medRxiv	2023
37459578	Immune Resistance Mechanisms and the Road to Personalized Immunotherapy.	Am Soc Clin Oncol Educ Book	2023
37316351	Single-cell methylation sequencing data reveal succinct metastatic migration histories and tumor progression models.	Genome Res	2023
37282346	Glucose-6-Phosphate Dehydrogenase Deficiency and Coronavirus Disease 2019.	Clin Infect Dis	2023
37078793	Ubiquitin Ligases Siah1a/2 Control Alveolar Macrophage Functions to Limit Carcinogen-Induced Lung Adenocarcinoma.	Cancer Res	2023
37380628	A landscape of response to drug combinations in non-small cell lung cancer.	Nat Commun	2023
37308665	The GPCR-GÎ±<sub>s</sub>-PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure.	Nat Immunol	2023
37406115	Melanoma-intrinsic NR2F6 activity regulates antitumor immunity.	Sci Adv	2023
37270587	Optimizing cancer immunotherapy response prediction by tumor aneuploidy score and fraction of copy number alterations.	NPJ Precis Oncol	2023
37295398	Medication effects on the gut microbiome in allo-HCT.	Cell	2023
36789444	Decoupling the correlation between cytotoxic and exhausted T lymphocyte transcriptomic signatures enhances melanoma immunotherapy response prediction from tumor expression.	bioRxiv	2023
36789425	Predicting tumor immune microenvironment and checkpoint therapy response of head & neck cancer patients from blood immune single-cell transcriptomics.	bioRxiv	2023
36873924	Altered gene expression in excitatory neurons is associated with Alzheimer's disease and its higher incidence in women.	Alzheimers Dement (N Y)	2023
36513065	Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome.	Med	2023
36773602	Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesothelioma.	Cell Rep Med	2023
34340996	The tumour microenvironment shapes innate lymphoid cells in patients with hepatocellular carcinoma.	Gut	2022
35474866	MPA<sub>PASS</sub> software enables stitched multiplex, multidimensional EV repertoire analysis and a standard framework for reporting bead-based assays.	Cell Rep Methods	2022
35610202	Predicting cancer prognosis and drug response from the tumor microbiome.	Nat Commun	2022
35577818	Author Correction: A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing.	Nat Commun	2022
35502318	Synthetic lethality-based prediction of anti-SARS-CoV-2 targets.	iScience	2022
35632392	Clinical and Laboratory Features in the Israeli Population with COVID-19 Infection after Pfizer-BioNTech mRNA Booster Vaccination.	Vaccines (Basel)	2022
35597871	Gene-expression profiles of pretreatment biopsies predict complete response of rectal cancer patients to preoperative chemoradiotherapy.	Br J Cancer	2022
36600603	Fibrolamellar carcinoma transcriptomic-based treatment prediction: complete response after nivolumab and ipilimumab.	J Immunother Cancer	2022
36497367	Sex Biases in Cancer and Autoimmune Disease Incidence Are Strongly Positively Correlated with Mitochondrial Gene Expression across Human Tissues.	Cancers (Basel)	2022
36307411	Strain level microbial detection and quantification with applications to single cell metagenomics.	Nat Commun	2022
36099885	Race is a key determinant of the human intratumor microbiome.	Cancer Cell	2022
36064595	Big data in basic and translational cancer research.	Nat Rev Cancer	2022
35899587	Astrocyte immunometabolic regulation of the tumour microenvironment drives glioblastoma pathogenicity.	Brain	2022
35895872	AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer.	Cancer Discov	2022
35921407	Cross-species identification of cancer resistance-associated genes that may mediate human cancer risk.	Sci Adv	2022
35980743	MCP-1/CCR2 axis inhibition sensitizes the brain microenvironment against melanoma brain metastasis progression.	JCI Insight	2022
36050469	NRF2 mediates melanoma addiction to GCDH by modulating apoptotic signalling.	Nat Cell Biol	2022
34983745	Deconvolving Clinically Relevant Cellular Immune Cross-talk from Bulk Gene Expression Using CODEFACS and LIRICS Stratifies Patients with Melanoma to Anti-PD-1 Therapy.	Cancer Discov	2022
35338126	The landscape of receptor-mediated precision cancer combination therapy via a single-cell perspective.	Nat Commun	2022
35196484	Nucleoporin-93 reveals a common feature of aggressive breast cancers: robust nucleocytoplasmic transport of transcription factors.	Cell Rep	2022
35018390	Predicting COVID-19 severity using major risk factors and received vaccines.	medRxiv	2022
34555175	Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics.	Neuro Oncol	2022
33318707	Publisher Correction: Mutation-selection balance and compensatory mechanisms in tumour evolution.	Nat Rev Genet	2021
33674593	Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma.	Nat Commun	2021

1 - 50 of 316

Kahn Rhrissorrakrai

T.J. Watson Research Center

Career Start Year 2008

Number of shared co-authors 2

Neda Bagheri

University of Washington

Career Start Year 2007

Number of shared co-authors 0

Yuanfang Guan

University of Michigan ann arbor

Career Start Year 2007

Number of shared co-authors 2

Areejit Samal

The Institute of Mathematical Sciences (IMSc)

Career Start Year 2006

Number of shared co-authors 0

Angela Re

Fondazione Istituto Italiano di Tecnologia

Career Start Year 2006

Number of shared co-authors 0

Tommaso Mazza

Fondazione IRCCS Casa Sollievo della Sofferenza,71013

Career Start Year 2005

Number of shared co-authors 1

Julio Saez-Rodriguez

Institute of Computational Biomedicine, Heidelberg University

Career Start Year 2004

Number of shared co-authors 9

Holger Fr??hlich

Bonn-Aachen International Center for IT (B-IT), University of Bonn

Career Start Year 2004

Number of shared co-authors 0

Bin Zhang

Graduate School of Medicine, The University of Tokyo

Career Start Year 2004

Number of shared co-authors 1

Mikael Huss

Stockholm University

Career Start Year 2003

Number of shared co-authors 6

Andrei Zinovyev

INSERM U, Institut Curie, PSL Research University

Career Start Year 2003

Number of shared co-authors 2

Mar??a Rodr??guez Mart??nez

Herbert Irving Cancer Research Center, Columbia University Medical Center

Career Start Year 2002

Number of shared co-authors 1

Nathan D Price

Institute for Systems Biology

Career Start Year 2002

Number of shared co-authors 6

Chen-Hsiang Yeang

Institute of Statistical Science

Career Start Year 2001

Number of shared co-authors 4

Ilya Shmulevich

Institute for Systems Biology

Career Start Year 2001

Number of shared co-authors 8

Frank Emmert-Streib

Tampere University

Career Start Year 2000

Number of shared co-authors 0

Tero Aittokallio

Institute for Molecular Medicine Finland (FIMM), University of Helsinki

Career Start Year 1999

Number of shared co-authors 4

Shannon K McWeeney

Oregon Health & Science University, University of California Berkeley

Career Start Year 1997

Number of shared co-authors 11

Roland Eils

Berlin Institute of Health (BIH) and Charite

Career Start Year 1995

Number of shared co-authors 14

Pietro Li??

University of Cambridge

Career Start Year 1994

Number of shared co-authors 0

Ioannis Xenarios

University of Lausanne

Career Start Year 1994

Number of shared co-authors 3

Joel S Bader

Johns Hopkins University

Career Start Year 1993

Number of shared co-authors 4

Jesper Tegn??r

King Abdullah University of Science and Technology (KAUST)

Career Start Year 1993

Number of shared co-authors 2

Andrea Califano

Columbia University

Career Start Year 1993

Number of shared co-authors 20

Fabian J Theis

Technical University of Munich

Career Start Year 1992

Number of shared co-authors 6

Andreas Beyer

University of Cologne

Career Start Year 1991

Number of shared co-authors 8

Zolt??n N Oltvai

University of Rochester

Career Start Year 1991

Number of shared co-authors 1

Gustavo Stolovitzky

IBM T.J. Watson Research Center

Career Start Year 1990

Number of shared co-authors 12

Shankar Subramaniam

University of California

Career Start Year 1989

Number of shared co-authors 6

Rainer Spang

University of Regensburg

Career Start Year 1969

Number of shared co-authors 2

row(s) 1 - 30 of 30

Roded Sharan

Tel Aviv University

Co-authored papers 46

Tomer Shlomi

Technion-Israel Institute of Technology

Co-authored papers 27

Alejandro A Sch??ffer

National Cancer Institute, National Institutes of Health

Co-authored papers 19

Nir Yosef

Center for Computational Biology, University of California berkeley

Co-authored papers 15

Keren Yizhak

Co-authored papers 14

Kenneth Aldape

National Cancer Institute

Co-authored papers 12

Ze'ev Ronai

Cancer Center, Sanford Burnham Prebys Medical Discovery Institute

Co-authored papers 12

Ariel Israel

Co-authored papers 11

Yardena Samuels

Weizmann Institute of Science

Co-authored papers 8

Tamar Geiger

Tel Aviv University

Co-authored papers 8

Fiorella Schischlik

National Cancer Institute, National Institutes of Health

Co-authored papers 8

Assaf Gottlieb

Center for Precision Health, University of Texas Health Science Center at Houston

Co-authored papers 7

Leandro C Hermida

University of Pittsburgh

Co-authored papers 6

Xin Wei Wang

Center for Cancer Research, National Cancer Institute (NCI)

Co-authored papers 6

Gao Zhang

Co-authored papers 6

Meenhard Herlyn

Ellen and Ronald Caplan Cancer Center, The Wistar Institute

Co-authored papers 6

Yongmei Feng

Cancer Center, Sanford Burnham Prebys Medical Discovery Institute

Co-authored papers 6

Laura Martin-Sancho

The Scripps Research Institute

Co-authored papers 5

Sumit K Chanda

The Scripps Research Institute

Co-authored papers 5

Yuan Pu